Clinical Pharmacology In Drug Development

Clinical Pharmacology In Drug Development

药物开发中的临床药理学

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Clinical Pharmacology In Drug Development》是由Wiley-Blackwell出版社于2012年创办的英文国际期刊(ISSN: 2160-7648,E-ISSN: 2160-7648),该期刊长期致力于药学领域的创新研究,主要研究方向为PHARMACOLOGY & PHARMACY。作为SCI、SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA未开放获取模式(OA占比0.5930...%),以发表药学领域等方向的原创性研究为核心(研究类文章占比99.15%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在117篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Clinical Pharmacology In Drug Development该刊近年未被列入国际预警名单,年发文量约117篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 117 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 267 / 356

25.1

学科:PHARMACOLOGY & PHARMACY SCIE Q3 239 / 356

33.01

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 265 / 354

25.3

学科:PHARMACOLOGY & PHARMACY SCIE Q3 218 / 354

38.56

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:3.4 SJR:0.553 SNIP:0.6
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmaceutical Science Q2 90 / 191

53%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology (medical) Q3 154 / 278

44%

期刊发文

  • Bioequivalence and Safety Assessment of Brivaracetam Dry Syrup Compared With Tablets in Healthy Japanese Participants: Results From Two Randomized Single- and Multiple-Dose Trial

    Author: Hayakawa, Yoshinobu; Yoshinaka, Ryoji; Sano, Tomonobu; Krauwinkel, Walter; Soma, Tadaharu; Sasamoto, Hiroshi; Elshoff, Jan-Peer; Bass, Almasa; Chen, Ying; Kurihara, Nozomi; Murakami, Harumi

    Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 4, pp. -. DOI: 10.1002/cpdd.70057

  • Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Voriconazole Tablets in Healthy Chinese Volunteer

    Author: Luo, Pan; Lei, Yongfang; Liu, Chang; Du, Juan; Deng, Xiangxiao; Yu, Hengyi; Qi, Xingxing; He, Zheng; Zhang, Dongling; Zuo, Qin; Fang, Yinian; Liu, Dong; Chen, Qian; Ren, Xiuhua

    Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 4, pp. -. DOI: 10.1002/cpdd.70058

  • Effect of High-Fat Diet on Pharmacokinetics and Incidence of Adverse Reactions of Tacrolimus in Healthy Chinese Participant

    Author: Zhu, Xiufang; Shi, Lingxue; Yang, Lan; Zhang, Nana; Wu, Yujie; Yin, Peihua; Wang, Jianxin; Zhou, Chunhua

    Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cpdd.70049

  • Pharmacokinetics and Bioequivalence of 2 Deutetrabenazine Tablets in Healthy Chinese Volunteers Under Fasting and Fed Condition

    Author: Xu, Dayong; Wang, Pengkai; Li, Yuan; Zhang, Ping; Wei, Liying; Xiong, Xiaolian; Li, Xin

    Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cpdd.70054

  • A Randomized, Double-Blind, Two-Treatment, Two-Period, Crossover Study Investigating the Systemic Bioavailability of a Novel Cocrystal Ubiquinol Formulation Compared with a Ubiquinone Formulation in Healthy Adult

    Author: Mei, Xuefeng; Zhu, Bingqing; Soni, Kshitij; Kasaraneni, Kishore; Panchal, Nirav

    Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cpdd.70042

  • Pharmacokinetic and Bioequivalence Evaluation of Two Lercanidipine Hydrochloride Tablets in Healthy Chinese Volunteer

    Author: Sun, Biao; Zhao, Li; Gan, Fangliang; Zhan, Qiong

    Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cpdd.70045

  • Pharmacokinetic Characterization and Bioequivalence of Sildenafil Citrate Orally Disintegrating Tablets in Healthy Volunteer

    Author: Zhang, Yi; Du, Lijie; Liu, Shirong; Chen, Guiying; Han, Haoran; Huang, Jiangeng; Jiang, Hongliang; Wang, Xiaolu; Guo, Dongsheng; Gan, Fangliang

    Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cpdd.70041

  • Pharmacokinetic and Bioequivalence Evaluation of Two Repaglinide Tablets Under Fasting and Fed Conditions in Healthy Chinese Volunteer

    Author: Sun, Biao; Zhao, Li; Gan, Fangliang; Zhan, Qiong

    Journal: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/cpdd.70044